Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy.
N Engl J Med
; 375(19): 1845-1855, 2016 11 10.
Article
in En
| MEDLINE
| ID: mdl-27717298
Full text:
1
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Adjuvants, Immunologic
/
Melanoma
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
Limits:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2016
Type:
Article